Universal-Beteiligungs- und Servicegesellschaft’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.91M Sell
13,304
-40
-0.3% -$11.3K 0.01% 1028
2026
Q1
$3.72M Buy
13,344
+1,572
+13% +$453K 0.01% 1002
2025
Q4
$3.57M Sell
11,772
-1,184
-9% -$369K 0.01% 1044
2025
Q3
$3.63M Buy
12,956
+4,541
+54% +$1.24M 0.01% 1020
2025
Q2
$2.03M Sell
8,415
-2,330
-22% -$551K ﹤0.01% 1242
2025
Q1
$2.62M Buy
10,745
+108
+1% +$32.5K 0.01% 1056
2024
Q4
$3.49M Buy
+10,637
New +$3.61M 0.01% 799

Other funds holding BIO

Universal-Beteiligungs- und Servicegesellschaft's BIO Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Bio-Rad Laboratories Class A (BIO) stake by 0.3% in Q2 2026, selling an estimated $11.3K and leaving 13,304 shares worth $3.91M. The position accounts for 0.01% of the portfolio, ranked #1028.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in BIO in Q4 2024 and has held it in 7 quarters since. 400 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 13,304 shares of Bio-Rad Laboratories Class A worth $3.91M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 40 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $11.3K.
  • Bio-Rad Laboratories Class A made up 0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1028 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Bio-Rad Laboratories Class A in Q4 2024 and has held it in 7 quarters since.
  • 400 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.